The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

NCT04475107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Pyronaridine-Artesunate
DRUG: Placebo

Sponsor

Shin Poong Pharmaceutical Co. Ltd.